There are 383 resources available
3MO - First-line camrelizumab plus carboplatin and paclitaxel for advanced squamous non-small-cell lung cancer: Updated overall survival results from the phase 3 CameL-sq trial
Presenter: Caicun Zhou
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
4MO - Final Overall Survival (OS) Data of Sintilimab Plus Pemetrexed (SPP) and Platinum as First-Line (1L) Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (AMnsqNSCLC) in the Phase 3 ORIENT -11 Study
Presenter: Yunpeng Yang
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Where do we stand?
Presenter: Matthijs Oudkerk
Session: Implementation of screening programmes in Europe
Resources:
Slides
Webcast
Reading guidelines
Presenter: Naama Bogot
Session: Implementation of screening programmes in Europe
Resources:
Slides
Webcast
Nodule investigation
Presenter: David R. Baldwin
Session: Implementation of screening programmes in Europe
Resources:
Slides
Webcast
Biomarkers in screening effort
Presenter: Luis Montuenga
Session: Implementation of screening programmes in Europe
Resources:
Slides
Webcast
Q&A
Session: Implementation of screening programmes in Europe
Resources:
Webcast
First shot on goal is the most important: Updates on first line therapy for limited stage and extensive stage SCLC
Presenter: Jarushka Naidoo
Session: Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer
Resources:
Slides
Webcast
Battling recurrent SCLC: Emerging therapies for platinum refractory disease
Presenter: Giuseppe Lo Russo
Session: Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer
Resources:
Slides
Webcast
Delivering on the promise of precision medicine in SCLC: Emerging molecular sub-types
Presenter: Benjamin Drapkin
Session: Not so small anymore: New therapies and cutting-edge science to guide the care of patients with small cell lung cancer
Resources:
Slides
Webcast